BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17584108)

  • 1. Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease.
    Arroyo AG; Genís L; Gonzalo P; Matías-Román S; Pollán A; Gálvez BG
    Curr Pharm Des; 2007; 13(17):1787-802. PubMed ID: 17584108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MT1-MMP: universal or particular player in angiogenesis?
    Genís L; Gálvez BG; Gonzalo P; Arroyo AG
    Cancer Metastasis Rev; 2006 Mar; 25(1):77-86. PubMed ID: 16680574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and angiogenesis.
    Rundhaug JE
    J Cell Mol Med; 2005; 9(2):267-85. PubMed ID: 15963249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metalloproteinases and their inhibitors in angiogenesis.
    Lafleur MA; Handsley MM; Edwards DR
    Expert Rev Mol Med; 2003 Sep; 5(23):1-39. PubMed ID: 14585170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of matrix metalloproteinase inhibitors: angiogenesis and tumor models.
    Albert DH; Davidsen SK
    Curr Protoc Pharmacol; 2001 Aug; Chapter 5():Unit5.23. PubMed ID: 21959760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
    Karagiannis ED; Popel AS
    J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interplay between endothelial nitric oxide synthase and membrane type 1 matrix metalloproteinase in migrating endothelial cells.
    Genís L; Gonzalo P; Tutor AS; Gálvez BG; Martínez-Ruiz A; Zaragoza C; Lamas S; Tryggvason K; Apte SS; Arroyo AG
    Blood; 2007 Oct; 110(8):2916-23. PubMed ID: 17606763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
    Fink K; Boratyński J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/ccl2 and interleukin-8/CXCL8 in endothelial cells during angiogenesis.
    Gálvez BG; Genís L; Matías-Román S; Oblander SA; Tryggvason K; Apte SS; Arroyo AG
    J Biol Chem; 2005 Jan; 280(2):1292-8. PubMed ID: 15516694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo.
    Ebrahem Q; Chaurasia SS; Vasanji A; Qi JH; Klenotic PA; Cutler A; Asosingh K; Erzurum S; Anand-Apte B
    Am J Pathol; 2010 Jan; 176(1):496-503. PubMed ID: 19948826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.
    van Hinsbergh VW; Koolwijk P
    Cardiovasc Res; 2008 May; 78(2):203-12. PubMed ID: 18079100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of human microvascular endothelial cell invasion and morphogenesis with synthetic matrixin inhibitors. Targeting angiogenesis with MMP inhibitors.
    Jia MC; Schwartz MA; Sang QA
    Adv Exp Med Biol; 2000; 476():181-94. PubMed ID: 10949665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration.
    Nyalendo C; Michaud M; Beaulieu E; Roghi C; Murphy G; Gingras D; Béliveau R
    J Biol Chem; 2007 May; 282(21):15690-9. PubMed ID: 17389600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericellular proteases in angiogenesis and vasculogenesis.
    van Hinsbergh VW; Engelse MA; Quax PH
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):716-28. PubMed ID: 16469948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis.
    Seiki M; Koshikawa N; Yana I
    Cancer Metastasis Rev; 2003; 22(2-3):129-43. PubMed ID: 12784992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The membrane tethered matrix metalloproteinase MT1-MMP at the forefront of melanoma cell invasion and metastasis.
    Thakur V; Bedogni B
    Pharmacol Res; 2016 Sep; 111():17-22. PubMed ID: 27221755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.
    Poincloux R; Lizárraga F; Chavrier P
    J Cell Sci; 2009 Sep; 122(Pt 17):3015-24. PubMed ID: 19692588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Roles of MT1-MMP and MMP-2: Beyond the Extracellular Milieu.
    Maybee DV; Ink NL; Ali MAM
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MT1-MMP: a potent modifier of pericellular microenvironment.
    Itoh Y; Seiki M
    J Cell Physiol; 2006 Jan; 206(1):1-8. PubMed ID: 15920734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
    Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
    Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.